|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:AstraZeneca
gptkb:Alexion_Pharmaceuticals
gptkb:MedImmune
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:CEO
|
gptkb:Pascal_Soriot
|
|
gptkbp:clinicalTrials
|
ongoing
extensive
chronic diseases
acute diseases
phases I, II, III
|
|
gptkbp:collaboratedWith
|
gptkb:Astra_AB
|
|
gptkbp:collaborations
|
gptkb:University_of_Oxford
with healthcare providers
with NGOs
with governments
|
|
gptkbp:communityEngagement
|
various programs
|
|
gptkbp:divisions
|
research and development
manufacturing
biotechnology
pharmaceuticals
commercial operations
|
|
gptkbp:employees
|
70,600 (2020)
|
|
gptkbp:financialPerformance
|
strong
|
|
gptkbp:focus
|
biopharmaceuticals
|
|
gptkbp:founded
|
1993
|
|
gptkbp:headCoach
|
multiple scientists
|
|
gptkbp:headquarters
|
gptkb:Cambridge
gptkb:Cambridge,_England
|
|
gptkbp:history
|
formed_from_the_merger_of_ICI's_pharmaceutical_division_and_Astra_AB.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zeneca Group
|
|
gptkbp:impact
|
gptkb:AstraZeneca_vaccine
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:innovation
|
focus on new therapies
|
|
gptkbp:internationalCooperation
|
over 100 countries
|
|
gptkbp:investmentFocus
|
in research and development
|
|
gptkbp:manufacturer
|
gptkb:Cambridge,_UK
|
|
gptkbp:market
|
global
$140 billion (2021)
|
|
gptkbp:partnerships
|
biotech companies
various academic institutions
|
|
gptkbp:patentCitation
|
numerous
|
|
gptkbp:philanthropy
|
environmental initiatives
education initiatives
health initiatives
|
|
gptkbp:previousName
|
gptkb:AstraZeneca
|
|
gptkbp:products
|
medicines
|
|
gptkbp:research_areas
|
oncology
infectious diseases
immunology
cardiovascular
respiratory
|
|
gptkbp:researchAndDevelopment
|
$6.1 billion (2020)
|
|
gptkbp:revenue
|
$26.6 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:LSE
|
|
gptkbp:stockSymbol
|
AZN
|
|
gptkbp:sustainabilityInitiatives
|
governance
social responsibility
environmental responsibility
|
|
gptkbp:tributaryOf
|
diverse portfolio of drugs
|